Detalles de la búsqueda
1.
Novel potent (dihydro)benzofuranyl piperazines as human histamine receptor ligands - Functional characterization and modeling studies on H3 and H4 receptors.
Bioorg Med Chem
; 30: 115924, 2021 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33333448
2.
Therapeutic potential of LINS01 histamine H3 receptor antagonists as antineoplastic agents for triple negative breast cancer.
Biomed Pharmacother
; 174: 116527, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38579399
3.
Evaluation of the histamine H3 receptor antagonists from LINS01 series as cholinesterases inhibitors: Enzymatic and modeling studies.
Chem Biol Drug Des
; 100(5): 722-729, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36050829
4.
Novel potent vasodilating agents: Evaluation of the activity and potency of LINS01005 and derivatives in rat aorta.
Eur J Pharm Sci
; 143: 105171, 2020 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31805391
5.
Pharmacological Characterization of 5-Substituted 1-[(2,3-dihydro-1-benzofuran-2-yl)methyl]piperazines: Novel Antagonists for the Histamine H3 and H4 Receptors with Anti-inflammatory Potential.
Front Pharmacol
; 8: 825, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29184503
Resultados
1 -
5
de 5
1
Próxima >
>>